Revamping US pharma manufacturing: Trump’s executive order faces industry doubts

finance.yahoo.com/news/revamping-us-pharma-manufacturing-trump-141839699.html

US President Donald Trump has issued an executive order aimed at easing regulatory challenges for domestic pharmaceutical producers while imposing stricter conditions on foreign manufacturers. The executive order, signed on 5 May 2025, instructs the US Food and Drug Administration (FDA)…

This story appeared on finance.yahoo.com, 2025-05-16 14:18:39.
The Entire Business World on a Single Page. Free to Use →